Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

rolapitant hydrochloride

(roh-LA-pih-tunt HY-droh-KLOR-ide)
A drug used with other drugs in adults to prevent nausea and vomiting caused by chemotherapy. Rolapitant hydrochloride blocks the action of a certain chemical in the central nervous system that may trigger nausea and vomiting. Blocking this chemical may lessen nausea and vomiting. Rolapitant hydrochloride is a type of antiemetic and a type of substance P/neurokinin 1 receptor antagonist. Also called Varubi.
More Information
Search NCI's Dictionary of Cancer Terms